| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3628 |
| Trial ID | NCT06092047 |
| Disease | B-Cell Malignancy |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UTAA09 |
| Recruitment status | Not Recruiting |
| Title | UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies. |
| Year | 2023 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-CART-UTAA09-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||